RESUMEN
Canine intranasal carcinomas are almost always malignant. Surgery alone often results in rapid tumor regrowth. Radiotherapy is the treatment of choice for dogs with intranasal tumors. Here, we retrospectively assessed treatment of intranasal carcinoma by marginal tumor resection followed by intraoperative acridine orange (AO) photodynamic therapy (PDT) and cribriform plate electron-beam intraoperative radiotherapy (IORT). Fourteen canine cases were assessed, 12 of which had stage I tumors, one with stage III, and one with stage IV. Recurrence was detected in 8, with a median recurrence from the time of treatment of 6 months (range: 3 to 16 months). The median progression-free survival time and overall survival time after treatment were 13 and 22 months, respectively. Adverse events were mild. Marginal tumor resection followed by intraoperative AO-PDT and cribriform plate electron-beam IORT may increase the tumor control time in dogs with marginally resectable intranasal malignant tumors beyond that incurred by surgery alone.
Thérapie photodynamique peropératoire à l'acridine orange et irradiation par faisceau électrique pour carcinome intranasal canin : 14 cas. Un carcinome intranasal canin est presque toujours malin. Une simple opération chirurgicale résulte souvent dans la rapide réapparition de la tumeur. Dans cet article, nous discutons d'un traitement d'un carcinome intranasal par résection marginale de la tumeur effectué simultanément à une thérapie photodynamique (TPD) peropératoire à l'acridine orange (AO) et une radiothérapie peropératoire (RPO) par faisceau électrique des lames criblées. L'étude a porté sur quatorze cas chez le chien dont 12 tumeurs étaient classées au stade I, une au stade III et une au stade IV. Huit des cas étaient des cas de récidive selon une moyenne de 6 mois depuis la période du traitement (plage de 3 à 16 mois). Le temps de survie moyen à l'état stabilisé et le temps de survie général après traitement étaient respectivement de 13 et 22 mois. Les incidents thérapeutiques sont moindres (cinq cas d'emphysème sous-cutané et quatre cas de rhinite). La résection marginale de la tumeur conduite simultanément avec une TPD-AO peropératoire et une RPO par faisceau électrique des lames criblées semble permettre une plus longue phase de maîtrise des tumeurs chez le chien porteur d'une tumeur intranasale maligne à résection marginales possible par rapport aux résultats obtenus par simple intervention chirurgicale.(Traduit par les auteurs).
Asunto(s)
Naranja de Acridina , Enfermedades de los Perros , Fotoquimioterapia/veterinaria , Animales , Terapia Combinada/veterinaria , Perros , Electrones , Cuidados Intraoperatorios/veterinaria , Recurrencia Local de Neoplasia/veterinaria , Estudios RetrospectivosRESUMEN
The sodium-independent cystine-glutamate antiporter plays an important role in extracellular cystine uptake. It comprises the transmembrane protein, xCT and its chaperone, CD98. Because glutathione is only weakly cell membrane permeable, cellular uptake of its precursor, cystine, is known to be a key step in glutathione synthesis. Moreover, it has been reported that xCT expression affects the progression of tumors and their resistance to therapy. Sulfasalazine is an inhibitor of xCT that is known to increase cellular oxidative stress, giving it anti-tumor potential. Here, we describe a radio-sensitizing effect of sulfasalazine using a B16F10 melanoma model. Sulfasalazine decreased glutathione concentrations and resistance to H2O2 in B16F10 melanoma cells, but not in mouse embryonic fibroblasts. It synergistically enhanced the cyto-killing effect of X-irradiation in B16F10 cells. It inhibited cellular DNA damage repair and prolonged cell cycle arrest after X-irradiation. Furthermore, in an in vivo transplanted melanoma model, sulfasalazine decreased intratumoral glutathione content, leading to enhanced susceptibility to radiation therapy. These results suggest the possibility of using SAS to augment the treatment of radio-resistant cancers.
Asunto(s)
Daño del ADN/efectos de los fármacos , Melanoma Experimental/tratamiento farmacológico , Melanoma Experimental/radioterapia , Sulfasalazina/farmacología , Animales , Antiportadores/metabolismo , Ciclo Celular , Supervivencia Celular , Ensayo Cometa , Cistina/metabolismo , Reparación del ADN , Femenino , Fibroblastos/metabolismo , Ácido Glutámico/metabolismo , Peróxido de Hidrógeno/metabolismo , Ratones , Ratones Endogámicos C57BL , Estrés Oxidativo , Interferencia de ARN , ARN Interferente Pequeño/metabolismo , Tolerancia a Radiación , Especies Reactivas de Oxígeno/metabolismo , Rayos XRESUMEN
The purpose of this study was to verify the applicability of measurement of slice thickness of magnetic resonance imaging (MRI) by the delta method, and to discuss the measurement precision by the disk diameter and baseline setup of the slice profile of the delta method. The delta method used the phantom which put in the disk made of acrylic plastic. The delta method measured the full width at half maximum (FWHM) and the full width at tenth maximum (FWTM) from the slice profile of the disk signal. Evaluation of the measurement precision of the delta method by the disk diameter and baseline setup were verified by comparison of the FWHM and FWTM. In addition, evaluation of the applicability of the delta method was verified by comparison of the FWHM and FWTM using the wedge method. The baseline setup had the proper signal intensity of an average of 10 slices in the disk images. There were statistically significant difference in the FWHM between disk diameter of 10 mm and disk diameter of 30 mm and 5 mm. The FWHM of the disk diameter of 10 mm was smaller than the disk diameter of 30 mm and 5 mm. There was no statistically significant difference in the FWHM between the delta method and the wedge method. There is no difference in the effective slice thickness of the delta method and the wedge method. The delta method has an advantage in measurement of thin slice thickness.